Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Scott · SciRah

Researcher profile · Semantic Scholar

N. Scott

Share profile

N. Scott — researcher profile on SciRah

h-index: 13
Works: 29
Citations: 1,376

Most-cited papers

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
S. Dorman, Payam Nahid, E. Kurbatova, P. Phillips +27 more
2021New England Journal of Medicine374 citations Open access
Semantic Scholar
Treatment for Preventing Tuberculosis in Children and Adolescents
M. Villarino, N. Scott, Stephen E Weis, M. Weiner +8 more
2015JAMA pediatrics219 citations Open access
Semantic Scholar
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection
R. Belknap, David P. Holland, Pei-Jean I. Feng, J. Millet +11 more
2017Annals of Internal Medicine148 citations Open access
Semantic Scholar
Three Months of Weekly Rifapentine plus Isoniazid for Treatment of M. tuberculosis Infection in HIV Co-infected Persons
T. Sterling, N. Scott, J. Miró, G. Calvet +8 more
2016AIDS (London)141 citations Open access
Semantic Scholar
SARS-CoV-2-Associated Deaths Among Persons Aged <21 Years - United States, February 12-July 31, 2020.
Danae Bixler, Allison D. Miller, Claire P. Mattison, B. Taylor +87 more
2020MMWR. Morbidity and mortality weekly report140 citations Open access
Semantic Scholar
Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States
D. Shepardson, S. M. Marks, H. Chesson, A. Kerrigan +9 more
2013The International Journal of Tuberculosis and Lung Disease73 citations Open access
Semantic Scholar
Exposure to Latent Tuberculosis Treatment during Pregnancy
R. Moro, N. Scott, A. Vernon, Naomi K. Tepper +12 more
2018Annals of the American Thoracic Society51 citations Open access
Semantic Scholar
Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada
Ruth N. Moro, A. Borisov, J. Saukkonen, Awal Khan +6 more
2016Clinical Infectious Diseases44 citations Open access
Semantic Scholar
Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis Infection.
M. Weiner, R. Savic, William R. Mac Kenzie, Diane Wing +11 more
2014Journal of the Pediatric Infectious Diseases Society44 citations
Semantic Scholar
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis
N. Winters, R. Belknap, A. Benedetti, A. Borisov +11 more
2023The Lancet Respiratory Medicine40 citations Open access
Semantic Scholar
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: study protocol for TBTC Study 31/ACTG A5349 phase 3 clinical trial
S. Dorman, Payam Nahid, E. Kurbatova, S. Goldberg +28 more
2020Contemporary Clinical Trials40 citations Open access
Semantic Scholar
Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection.
Claire Sadowski, R. Belknap, D. Holland, R. Moro +7 more
2023Clinical Infectious Diseases15 citations Open access
Semantic Scholar
Rifapentine with and without moxifloxacin for pulmonary tuberculosis in people with HIV (S31/A5349).
A. Pettit, P. Phillips, E. Kurbatova, A. Vernon +18 more
2022Clinical Infectious Diseases14 citations Open access
Semantic Scholar
Optimizing Drug Inventory Management with a Web-based Information System: The TBTC Study 31 / ACTG A5349 Experience
N. Scott, K. K. Lee, Claire Sadowski, E. Kurbatova +14 more
2021Contemporary Clinical Trials11 citations Open access
Semantic Scholar
Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine
N. Scott, Claire Sadowski, A. Vernon, Bert Arevalo +11 more
2023Contemporary Clinical Trials8 citations Open access
Semantic Scholar
Agribusiness and Commodity Risk: Strategies and Management
N. Scott
20036 citations
Semantic Scholar
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes
E. Kurbatova, William C. Whitworth, L. Peddareddy, P. Phillips +16 more
2025Emerging Infectious Diseases4 citations Open access
Semantic Scholar
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase TB Trials.
E. Kurbatova, P. Phillips, S. Dorman, E. Sizemore +27 more
2023American Journal of Respiratory and Critical Care Medicine4 citations Open access
Semantic Scholar
Nonparticipation reasons in a randomized international trial of a new latent tuberculosis infection regimen
Kimberley N. Chapman Hedges, A. Borisov, J. Saukkonen, N. Scott +8 more
2019Clinical Trials3 citations Open access
Semantic Scholar
Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016–2020
E. Kurbatova, William C. Whitworth, Kia Bryant, Meredith G. Dixon +17 more
2025Emerging Infectious Diseases2 citations Open access
Semantic Scholar
Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35)
I. Courtney, Meredith G. Dixon, L. E. van der Laan, Rada Savic +16 more
2026JMIR Research Protocols0 citations Open access
Semantic Scholar
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC Study 38/CRUSH-TB design
E. Kurbatova, Kelly E. Dooley, Wendy Carr, J. Stout +23 more
2025Contemporary Clinical Trials0 citations
Semantic Scholar
Efavirenz pharmacokinetics and HIV-1 viral suppression among patients receiving TB treatment containing daily high-dose rifapentine.
A. Podany, Michelle M. Pham, E. Sizemore, N. Martinson +21 more
2021Clinical Infectious Diseases0 citations Open access
Semantic Scholar
SUPPLEMENTARY FIGURE 1. Weekly COVID-19 incidence in case surveillance data* by age group and U.S. Census Region† — United States, May 31–September 5, 2020
Danae Bixler, Allison D. Miller, Claire P. Mattison, B. Taylor +82 more
20200 citations
Semantic Scholar
SUPPLEMENTARY FIGURE 2. Total weekly SARS-CoV-2 RT-PCR test volume and percentage of weekly tests* by age group and U.S. Census Region† — United States, May 31–September 5, 2020
Danae Bixler, Allison D. Miller, Claire P. Mattison, B. Taylor +82 more
20200 citations
Semantic Scholar
SUPPLEMENTARY FIGURE 3. Weekly COVID-19 incidence in case surveillance data* among persons aged 18–22 years, by race and ethnic group† and U.S. Census Region§ — United States, May 31–September 5, 2020
Danae Bixler, Allison D. Miller, Claire P. Mattison, B. Taylor +82 more
20200 citations
Semantic Scholar
Hot Topic – Latente Tuberkulose-Infektion: 12-wöchige Therapie mit Rifapentin und Isoniazid zur Prävention ab 2 Jahren von der FDA zugelassen
M. Villarino, N. Scott, S. Weis, T. Sterling
2015Pneumologie0 citations Open access
Semantic Scholar
The Cost-Effectiveness Of 3 Months Of Weekly, Directly-Observed Rifapentine Plus Isoniazid (3HP) Vs. 9 Months Of Daily, Self-Administered Isoniazid (9H) For The Treatment Of Latent Tuberculosis Infection
D. Shepardson, S. Marks, D. Holland, H. Chesson +8 more
2012Asian Test Symposium0 citations
Semantic Scholar
An Application of Armitage Trend Test to Genome-wide Association Studies
N. Scott
20090 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Chaisson×10
Invite
R. Chaisson — researcher profile on SciRah
E. Sizemore×9
Invite
E. Sizemore — researcher profile on SciRah
Payam Nahid×8
Invite
Payam Nahid — researcher profile on SciRah
Kia Bryant×8
Invite
Kia Bryant — researcher profile on SciRah

×8

Invite

A. Borisov — researcher profile on SciRah

Invite

S. Goldberg — researcher profile on SciRah

Invite

A. Vernon — researcher profile on SciRah

M. Villarino×7

Invite

M. Villarino — researcher profile on SciRah

E. Kurbatova×6

Invite

E. Kurbatova — researcher profile on SciRah

Invite

T. Sterling — researcher profile on SciRah

Invite

K. Dooley — researcher profile on SciRah

Invite

W. Samaneka — researcher profile on SciRah